Precision Neuroscience
↗New York City, United States
Precision Neuroscience is a brain-computer interface (BCI) company founded in 2021 that develops minimally invasive neural implants to restore communication and motor control to patients with paralysis and neurological conditions. The company's flagship technology, the Layer 7 Cortical Interface, features 1,024 microelectrodes on a thin-film array about the size of a postage stamp, designed to be implanted on the cerebral cortex without penetrating brain tissue. Precision's approach is less invasive than competing BCIs and can be reversibly implanted, positioning it as a leader in clinical-ready neural interface technology. The company operates across multiple continents with offices in New York City (headquarters), Santa Clara (California), Addison (Texas), and Minneapolis (Minnesota), with a team of 117 employees as of early 2026.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Brain-Computer Interfaces (BCI) / Neurotech
SIZE & FINANCIALS
Employees:101-500
Revenue:Not disclosed
Founded:2021
Ownership:private
Status:operating
FUNDING
Stage:Series C
Total Raised:$155M
Investors:General Equity Holdings, Steadview Capital, B Capital, Duquesne Family Office (Stanley F. Druckenmiller), Alumni Ventures
PIPELINE
Stage:FDA Cleared / Commercial
Lead Drug Stage:Layer 7-T Cortical Interface - FDA 510(k) cleared March 30, 2025
Modalities:Thin-film microelectrode arrays, Implantable neural interface
Active Trials:37
Trial Phases:Phase 4: 37
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Lawrence Livermore National Laboratory (LLNL) - neural implant development collaboration, Mount Sinai Health System - clinical trials, University of Pennsylvania (Perelman School of Medicine) - clinical trials, West Virginia University Rockefeller Neuroscience Institute - clinical trials
COMPETITION
Position:Leader
Competitors:Neuralink (Elon Musk), Synchron, Blackrock Neurotech
LEADERSHIP
Key Executives:
Michael Mager - Co-Founder & Chief Executive Officer
Dr. Benjamin Rapoport - Co-Founder & Chief Science Officer
Craig Mermel - President & Chief Product Officer
Mike Kaswan - Chief Financial Officer
Brian Otis - Chief Technology Officer
John Woock - Chief Business Officer
Jayme Strauss - Chief Clinical and Commercial Officer
Vanessa Tolosa, PhD - Senior Vice President, Research & Development
Vivek Pinto, PhD, MBA - Director, Medical Affairs
Scientific Founders:Benjamin Rapoport, Michael Mager, Demetrios Papageorgiou, Mark Hettick
Board Members:Konstantinos Alataris, Ph.D.
LINKS
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Precision Neuroscience and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Precision Neuroscience. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.